Summit Therapeutics competitors

Summit Therapeutics Competitors include STERIS, BioScrip, Perrigo and BioDelivery Sciences International.
Add company...
Summit Therapeutics
Summit Therapeutics
Summit Therapeutics is an international biopharmaceutical company focussed on the discovery and development of novel medicines to treat the fatal muscle wasting disease Duchenne muscular dystrophy and infections caused by the bacteria C. difficile.
STERIS
STERIS
STERIS Corporation offers customized infection prevention and contamination control solutions for a variety of environments.
BioScrip
BioScrip
We are a national post-acute solutions provider with over 30 years of experience.
Perrigo
Perrigo
Global healthcare supplier.
BioDelivery Sciences International
BioDelivery Sciences International
BioDelivery Sciences is a specialty pharmaceutical company with a focus in the areas of pain management and addiction medicine.
Founding Date
Founding Date
2003
Founding Date
1987
Founding Date
N/A
Founding Date
1887
Founding Date
1997
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Milton, GB HQ
Cambridge, US
Locations
Mentor, US HQ
Mentor, US
Locations
Denver, US HQ
Elmsford, US
Eden Prairie, US
Locations
Dublin, IE HQ
Allegan, US
Locations
Raleigh, US HQ
Employees
Employees
44
Employees
12,000
Employees
1,72715% decrease
Employees
13,300
Employees
40
Valuation ($)
Valuation ($)
127.5 m
Valuation ($)
9.9 b
Valuation ($)
512.2 m
Valuation ($)
8 b
Valuation ($)
252.4 m
Twitter followers
Twitter followers
898
Twitter followers
2.7 k
Twitter followers
291
Twitter followers
1.6 k
Twitter followers
286

Financial

Revenue (est.)
Revenue (est.)
£25.4m (FY, 2018)
Revenue (est.)
$2.6b (FY, 2018)
Revenue (est.)
$817.2m (FY, 2017)
Revenue (est.)
$1.3b (FY, 2016)
Revenue (est.)
$62m (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
$1.5b (FY, 2018)
Cost of goods
$547.9m (FY, 2017)
Cost of goods
N/A
Cost of goods
$19.5m (FY, 2017)
Gross profit
Gross profit
N/A
Gross profit
$1.1b (FY, 2018)
Gross profit
$269.2m (FY, 2017)
Gross profit
N/A
Gross profit
$42.5m (FY, 2017)
Net income
Net income
(£7.1m) (FY, 2018)
Net income
$290.9m (FY, 2018)
Net income
($64.2m) (FY, 2017)
Net income
($1.4b) (FY, 2016)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 109.5m
Total funding raised
N/A
Total funding raised
$ 60m
For sources of this data, please see the company profileDownload Excel

View company profiles

STERIS
HQ
Mentor, US
Employees
12,000

STERIS Corporation offers customized infection prevention and contamination control solutions for a variety of environments.

View company
BioScrip
HQ
Denver, US
Employees
1,727↓ 15% decrease

We are a national post-acute solutions provider with over 30 years of experience.

View company
Perrigo
HQ
Dublin, IE
Employees
13,300

Global healthcare supplier.

View company
BioDelivery Sciences International
HQ
Raleigh, US
Employees
40

BioDelivery Sciences is a specialty pharmaceutical company with a focus in the areas of pain management and addiction medicine.

View company